Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 3 trial
Yan Zhao(University of California, Los Angeles), Jianzhong Zhang(Peking University), Litao Zhang(Tianjin University of Traditional Chinese Medicine)
Cited by 35
Related Papers
Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity
|Proceedings of the National Academy of Sciences|2015|168
Characterization of PSI recovery after chilling-induced photoinhibition in cucumber (Cucumis sativus L.) leaves
|Planta|2011|117
Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis
|Chinese Medical Journal|2016|110
Characterization of Photosynthetic Performance during Senescence in Stay-Green and Quick-Leaf-Senescence Zea mays L. Inbred Lines
|PLoS ONE|2012|98
Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
|Frontiers in Immunology|2022|93